Journal of Controlled Release 2020

5 papers
In 2020, research in the Journal of Controlled Release focused on stimuli-responsive delivery systems and nanocarriers designed for oncology and vaccine development. Studies explored mechanisms to overcome chemoresistance and improve tumor accumulation, utilizing technologies such as heat-triggered gold nanocages and iron-crosslinked Rososomes. Another area of investigation involved core-shell nanoparticles featuring polyphenol-cisplatin complexation for dual-responsive drug release. The year’s publications also addressed immunological applications, particularly for chronic hepatitis B. Research examined the use of cationic poly(lactic acid) microparticles and pH-responsive liposomes to facilitate cytosolic delivery and enhance cellular immunity. These works reflect a trend toward engineering delivery vehicles that respond to specific environmental triggers to optimize therapeutic outcomes. Key contributors to these developments included researchers such as Fumin Hu, Guanghui Ma, and Hua Yue. Collectively, the research from this year highlights the integration of material science and biological targeting to improve the stability and efficacy of therapeutic agents.

Top Authors

AuthorPapers
Hua Yue2

Papers

Title
Cytosolic delivery of HBsAg and enhanced cellular immunity by pH-responsive liposome
Iron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy
Polyphenol-cisplatin complexation forming core-shell nanoparticles with improved tumor accumulation and dual-responsive drug release for enhanced cancer chemotherapy
Smart gold nanocages for mild heat-triggered drug release and breaking chemoresistance
The incorporation of cationic property and immunopotentiator in poly (lactic acid) microparticles promoted the immune response against chronic hepatitis B